Patent: 6,872,397
✉ Email this page to a colleague
Summary for Patent: 6,872,397
Title: | Method for treating neuromuscular disorders and conditions with botulinum toxin types A and B |
Abstract: | A method of treating a patient suffering from a disease, disorder or condition includes the administration to the patient of a therapeutically effective amount of botulinum toxin of a selected serotype until the patient experiences loss of clinical response to the administered botulinum toxin and thereafter administering to the patient a therapeutically effective amount of another botulinum toxin of a different serotype. |
Inventor(s): | Aoki; K. Roger (Laguna Hills, CA), Grayston; Michael W. (Irvine, CA), Carlson; Steven R. (Laguna Nigel, CA), Leon; Judith M. (Laguna Niguel, CA) |
Assignee: | Allergan, Inc. (Irvine, CA) |
Application Number: | 09/812,113 |
Patent Claims: | see list of patent claims |
Details for Patent 6,872,397
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Solstice Neurosciences, Llc | MYOBLOC | rimabotulinumtoxinb | Injection | 103846 | 12/08/2000 | ⤷ Try a Trial | 2013-06-10 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 6,872,397
Country | Patent Number | Estimated Expiration |
---|---|---|
Australia | 689115 | ⤷ Try a Trial |
Australia | 7087894 | ⤷ Try a Trial |
Australia | 7319398 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |